Abstract

Narkotika yang disalahgunakan dapat menimbulkan ketergantungan. Semakin lama mengalami ketergantungan narkotika akan semakin memperburuk kualitas kesehatan. Pada pengguna narkoba suntik, komplikasi komorbiditas seperti hepatitis, tuberkulosis paru, dan HIV/AIDs juga semakin tinggi. Tujuan penelitian ini adalah mengetahui komorbiditas pada penyalah guna narkoba dan determinannya. Metode penelitian adalah potong lintang dengan menggunakan data sekunder catatan medis (medicalrecord) di Rumah Sakit Ketergantungan Obat (RSKO) Jakarta tahun 2013. Populasi dalam penelitian ini adalah seluruh pasien ketergantungan narkoba yang dirawat inap, yang menjalani rehabilitasi dan rawat jalan, dan sampel penelitian ini adalah seluruh populasi sebesar 303 orang. Analisis data yang digunakan adalah analisis secara univariat, bivariat, dan multivariat. Hasil penelitian menunjukkan bahwa pasien yang dirawat jalan dan lama menggunakan narkoba berhubungan dengan komorbiditas pada pecandu narkoba. Model akhir analisis multivariat menunjukkan bahwa lama menggunakan narkoba merupakan variabel yang paling berpengaruh terhadap komorbiditas pecandu narkoba. Narcotics are abused can lead to dependence. The longer experiencing drug dependence will worsen the quality of health care. In injecting drug users, complications such ashepatic, comorbidities, pulmonary TB, and HIV/AIDs also higher. The purpose of this study was to determine the comorbidity of drug abusers and its determinant. The method is a cross sectional study using secondary data, medical records at the Drug Dependence Hospital Jakarta in 2013. The study population were all drug dependent patients who are hospitalized, undergoing rehabilitation and outpatient care, and sample is total population of 303 people. Data were analyzed using univariate, bivariate and multivariate analyzes. The results showed that patients treated in outpatients and comorbidities associated with drug addicts. The final model of multivariate analysis showed that longer using drugs is the most influential variable on the comorbidity of drug addicts.

References

1. Badan Narkotika Nasional. Jurnal Data P4GN. Pencegahan, pemberantasan penyalahgunaan dan peredaran gelap narkoba. Jakarta: Badan Narkotika Nasional Republik Indonesia; 2013. 2. Departemen Kesehatan Republik Indonesia. Strategi promosi pencegahan penyalahgunaan napza di Indonesia. Jakarta: Departemen Kesehatan Republik Indonesia; 2001. 3. Breda Smyth, Valeria Hoffman, Jing Fan, Yih Ing Hser. Years of potential life lost heroin addicts 33 years after treatment. Preventive Medicine. 2007; (Suppl): 369-374. 4. Foster JH, Powell JE, Marshall EJ, Peters TJ. Quality of life in alcohol? dependent subjects: a review. Quality of Life Research. 1999; 8: 255–61. 5. Ries AL, Kaplan RM, Limberg TM, Prewitt LM. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Annual of Internal Medicine. 1995;122: 823-32. 6. Elizabeth C, Costenbader, Zule WA, Coomes CM. The impact of illicit drug use and harmful drinking on quality of life among injection drug users at high risk for hepatitis c infection. Drug and Alcohol Dependence. 2007; 89: 251–8. 7. Torrens M, Gilchrist G, Domingo-Salvany A, the psyco Barcelona Group. Psychiatric comorbidity in illicit drug user; substance induced versus independent disorder. Drug and Alcohol Dependence. 2011; 113: 147-56. 8. Keyes KM, Martins SS, Hasin DS. Past 12-month and life time comorbidity and poly drug use of ecstasy users among adults in the United States: result from the national epidemiologic survey on alcohol and related conditions. Drug and Alcohol Dependence. 2008; 97: 139-49. 9. Steesma C. Predictor of cessation of injecting drug use in a cohort of young, street-based injecting drugs [Thesis]. Montreal: Department of Epidemiology and Biostatistics McGill University; 2003. 10. Kemp R, Miller J, Lungley S, Baker M. Injecting behaviors and prevalence of hepatitis B, C and markers in New Zealand injecting drug user populations. New Zealand Medline Journals. 1998 Feb 27; 111(1060): 50-3. 11. Anne DB, Maria PC, Dominique R, Bruno S, Jean Albert G, Herve G, et al. Drug injection cessation among HIV infected injecting drug user. Addictive Behaviors. 2004; 29: 1189-97. 12. Campbell JV, Hagan H, Latka MH, Garfein RS, Golub ET, Coady MH, et al. High prevalence of alcohol use among hepatitis C virus antibody positive injection drug user in three US cities. Drug and Alcohol Dependence. 2006; 81: 259-65. 13. Fassino S, Daga GA, Delsedime N, Rogna L, Boggio S. Quality of life and personality disorder in heroin abuser. Drug and Alcohol Dependence. 2004; 76: 73-80. 14. Doweiko H. Concepts of chemical dependency. Wadswoorth, Brooks/ Cole Cengage Learning 10 Davis Drive Belmont, CA 94002-3098, USA; 2002. 15. Darmono. Toksikologi narkoba dan alkohol: pengaruh neurotoksisitasnya pada saraf otak. Jakarta: UI-Press; 2006. 16. Chen CY, Lin KM. Health consequences of illegal drug use. Current Opinion in Psychiatry. 2009; 22(3): 287-92. 17. Hahn JA, Page K, Shaper, Lum PJ, Ochoa K, Moss AR. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology. 2001; 34 (1). 18. Departemen Kesehatan Republik Indonesia. Undang-Undang Republik Indonesia Nomor 35 Tahun 2009 Tentang Narkotika. Jakarta: Departemen Kesehatan Republik Indonesia; 2009. 19. Mclellan AT, Lewis DC, Charles P, O’Brien. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcome evaluation. JAMA. 2000; 284(13); 1689-95. 20. Konopka A, Pelka J, Wysieka, Grzywacz A, Samochowiec J. Psychosocial characteristics of benzodiazepine addict compared to not addict benzodiazepine users. Progress in Neuropsychopharmacology and Biological Psychiatry. 2013 Jan 15; 40: 229-35.

Download

Share

COinS